191 related articles for article (PubMed ID: 34622875)
1. Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab.
Bertlich M; Ihler F; Bertlich I; Weiss BG; Gröger M; Haubner F
Medicine (Baltimore); 2021 Oct; 100(40):e27471. PubMed ID: 34622875
[TBL] [Abstract][Full Text] [Related]
2. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
3. Symptom Control of Patients With Chronic Rhinosinusitis With Nasal Polyps Under Maintenance Therapy With Daily Acetylsalicylic Acid.
Hahn J; Appel H; Scheithauer MO; Petereit F; Greve J; Lindemann J; Hoffmann TK; Veit JA; Sommer F
Am J Rhinol Allergy; 2020 Jul; 34(4):554-563. PubMed ID: 32208749
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease.
Yong M; Wu YQ; Howlett J; Ballreich J; Walgama E; Thamboo A
Int Forum Allergy Rhinol; 2021 Dec; 11(12):1626-1636. PubMed ID: 34309219
[TBL] [Abstract][Full Text] [Related]
5. [Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
Staufenberg AR; Frankenberger HK; Förster-Ruhrmann U; Spahn FC; Klimek L; Fruth K; Stihl C; Matthias C; Gröger M; Hagemann J
HNO; 2024 Jul; 72(7):473-483. PubMed ID: 38466409
[TBL] [Abstract][Full Text] [Related]
6. [Chronic rhinosinusitis with nasal polyposis : A retrospective analysis of therapeutic approaches in 463 patients].
Strauss J; Lochbaum R; Hoffmann TK; Mayer B; Appel H; Hahn J
HNO; 2024 Jul; 72(7):464-472. PubMed ID: 38700581
[TBL] [Abstract][Full Text] [Related]
7. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
[TBL] [Abstract][Full Text] [Related]
9. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements.
Pfaar O; Klimek L
Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):161-6. PubMed ID: 16670507
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery.
Kim JE; Kountakis SE
Ear Nose Throat J; 2007 Jul; 86(7):396-9. PubMed ID: 17702319
[TBL] [Abstract][Full Text] [Related]
11. Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis.
Batra PS; Tong L; Citardi MJ
Laryngoscope; 2013 Dec; 123 Suppl 7():S1-11. PubMed ID: 24122826
[TBL] [Abstract][Full Text] [Related]
12. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
Pfaar O; Klimek L
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
[TBL] [Abstract][Full Text] [Related]
13. Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Buchheit KM; Hacker J; Maurer R; McGill A; Ryan T; Bensko JC; Laidlaw TM
Clin Exp Allergy; 2023 Sep; 53(9):974-977. PubMed ID: 37246613
[No Abstract] [Full Text] [Related]
14. Clinical characteristics and aspirin desensitization in Thai patients with a suggestive history of NSAID-exacerbated respiratory disease.
Wongsa C; Sompornrattanaphan M; Tantilipikorn P; Thongngarm T
Asian Pac J Allergy Immunol; 2022 Sep; 40(3):247-253. PubMed ID: 31677617
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis.
Oykhman P; Paramo FA; Bousquet J; Kennedy DW; Brignardello-Petersen R; Chu DK
J Allergy Clin Immunol; 2022 Apr; 149(4):1286-1295. PubMed ID: 34543652
[TBL] [Abstract][Full Text] [Related]
16. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma.
Sweet JM; Stevenson DD; Simon RA; Mathison DA
J Allergy Clin Immunol; 1990 Jan; 85(1 Pt 1):59-65. PubMed ID: 2299107
[TBL] [Abstract][Full Text] [Related]
18. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis.
Bachert C; Zhang L; Gevaert P
J Allergy Clin Immunol; 2015 Dec; 136(6):1431-1440. PubMed ID: 26654192
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
Rajan JP; Wineinger NE; Stevenson DD; White AA
J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
[TBL] [Abstract][Full Text] [Related]
20. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day].
Gosepath J; Schäfer D; Mann WJ
Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
